Eli Lilly And reported $1.41B in Net Income for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 1232M 695M
Amgen AMGN:US $ 1803M 22M
AstraZeneca AZN:LN 648M 108M
Astrazeneca AZN:US $ 648M 108M
Baxter International BAX:US $ 246M 86M
Biogen BIIB:US $ 701.5M 840.6M
Bristol Myers Squibb BMY:US $ -85M 690M
Eli Lilly And LLY:US $ 1412M 44.5M
Endo International Ordinary Shares ENDP:US $ -75.89M 86.44M
Gilead Sciences GILD:US $ -3339M 4890M
GlaxoSmithKline GSK:LN 2263M 698M
Glaxosmithkline GSK:US $ 1244M 1019M
Horizon Pharma HZNP:US $ 292.84M 372.85M
Intercept Pharmaceuticals ICPT:US $ -63.28M 29.7M
JAZZ PHA JAZZ:US $ 148.23M 33.43M
Johnson & Johnson JNJ:US $ 3554M 72M
Medtronic MDT:US $ 487M 159M
Merk MRK:US $ 3002M 217M
Neurocrine Biosciences NBIX:US $ 79M 42M
Novartis NVS:US $ 1935M 68M
Perrigo Ordinary Shares PRGO:US $ -154.6M 215.2M
Pfizer PFE:US $ 3426M 25M
Regeneron Pharmaceuticals REGN:US $ 897.3M 272.7M
Revance Therapeutics RVNC:US $ -61M 1M
Teva Pharmaceutical Industries TEVA:US $ -4349M 4489M
United Therapeutics UTHR:US $ 107.1M 30.6M
Zoetis ZTS:US $ 377M 46M